

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 6.54858631 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.65109346 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.65109346 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.28191396 |
| 5 | * protein maturation by protein folding (GO:0022417) | 4.68448433 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.52668417 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.41108794 |
| 8 | nucleobase catabolic process (GO:0046113) | 4.32894921 |
| 9 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.28892374 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.28312942 |
| 11 | detection of calcium ion (GO:0005513) | 4.28162474 |
| 12 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.21777396 |
| 13 | synaptic vesicle maturation (GO:0016188) | 4.01424622 |
| 14 | negative regulation of norepinephrine secretion (GO:0010700) | 3.92976128 |
| 15 | peptide hormone processing (GO:0016486) | 3.92942614 |
| 16 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.91136078 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 3.88539001 |
| 18 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.86919814 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.83891555 |
| 20 | signal peptide processing (GO:0006465) | 3.80119403 |
| 21 | postsynaptic membrane organization (GO:0001941) | 3.75804193 |
| 22 | establishment of mitochondrion localization (GO:0051654) | 3.72178787 |
| 23 | regulation of oxidative phosphorylation (GO:0002082) | 3.70669208 |
| 24 | chaperone-mediated protein transport (GO:0072321) | 3.70577220 |
| 25 | endocrine pancreas development (GO:0031018) | 3.64692919 |
| 26 | glutamate secretion (GO:0014047) | 3.61936097 |
| 27 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.59393753 |
| 28 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.59393753 |
| 29 | * insulin secretion (GO:0030073) | 3.58860451 |
| 30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.57964238 |
| 31 | glycerophospholipid catabolic process (GO:0046475) | 3.54278040 |
| 32 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.52986512 |
| 33 | ER overload response (GO:0006983) | 3.51185534 |
| 34 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.47073415 |
| 35 | presynaptic membrane organization (GO:0097090) | 3.46184338 |
| 36 | neurofilament cytoskeleton organization (GO:0060052) | 3.45716298 |
| 37 | negative regulation of appetite (GO:0032099) | 3.45576523 |
| 38 | negative regulation of response to food (GO:0032096) | 3.45576523 |
| 39 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.44971353 |
| 40 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.44692183 |
| 41 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.44692183 |
| 42 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.44205162 |
| 43 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.44205162 |
| 44 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.43846514 |
| 45 | tachykinin receptor signaling pathway (GO:0007217) | 3.43104572 |
| 46 | short-term memory (GO:0007614) | 3.40376219 |
| 47 | behavioral response to cocaine (GO:0048148) | 3.40312445 |
| 48 | transferrin transport (GO:0033572) | 3.38570160 |
| 49 | behavioral response to nicotine (GO:0035095) | 3.32373929 |
| 50 | innervation (GO:0060384) | 3.31962307 |
| 51 | * regulation of insulin secretion (GO:0050796) | 3.29747013 |
| 52 | negative regulation of catecholamine secretion (GO:0033604) | 3.26811609 |
| 53 | protein retention in ER lumen (GO:0006621) | 3.24101746 |
| 54 | presynaptic membrane assembly (GO:0097105) | 3.23420656 |
| 55 | cell migration in hindbrain (GO:0021535) | 3.22258962 |
| 56 | positive regulation of neurotransmitter transport (GO:0051590) | 3.21093397 |
| 57 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.20444396 |
| 58 | neuron recognition (GO:0008038) | 3.19569035 |
| 59 | detection of temperature stimulus (GO:0016048) | 3.18893009 |
| 60 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.18329358 |
| 61 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.18329358 |
| 62 | neuron cell-cell adhesion (GO:0007158) | 3.16778382 |
| 63 | positive regulation of exocytosis (GO:0045921) | 3.16340693 |
| 64 | positive regulation of insulin secretion (GO:0032024) | 3.16142071 |
| 65 | proline transport (GO:0015824) | 3.12631558 |
| 66 | ferric iron transport (GO:0015682) | 3.11837462 |
| 67 | trivalent inorganic cation transport (GO:0072512) | 3.11837462 |
| 68 | cellular response to glucagon stimulus (GO:0071377) | 3.11406304 |
| 69 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.10162623 |
| 70 | axonal fasciculation (GO:0007413) | 3.09442004 |
| 71 | dendritic spine morphogenesis (GO:0060997) | 3.09249283 |
| 72 | positive regulation of protein homodimerization activity (GO:0090073) | 3.08078306 |
| 73 | chemosensory behavior (GO:0007635) | 3.07620459 |
| 74 | regulation of vesicle fusion (GO:0031338) | 3.06475531 |
| 75 | neuromuscular process controlling posture (GO:0050884) | 3.03169376 |
| 76 | mitochondrion transport along microtubule (GO:0047497) | 3.00159802 |
| 77 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.00159802 |
| 78 | * regulation of peptide hormone secretion (GO:0090276) | 2.99464025 |
| 79 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.97952038 |
| 80 | ATP synthesis coupled proton transport (GO:0015986) | 2.97952038 |
| 81 | protein complex biogenesis (GO:0070271) | 2.97100957 |
| 82 | * regulation of peptide secretion (GO:0002791) | 2.96700443 |
| 83 | cellular response to nicotine (GO:0071316) | 2.96467978 |
| 84 | positive regulation of synapse assembly (GO:0051965) | 2.96372253 |
| 85 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.95612812 |
| 86 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.95032545 |
| 87 | activation of protein kinase A activity (GO:0034199) | 2.94749894 |
| 88 | vesicle coating (GO:0006901) | 2.94066154 |
| 89 | regulation of cilium movement (GO:0003352) | 2.92868416 |
| 90 | neuronal action potential (GO:0019228) | 2.91462841 |
| 91 | COPII vesicle coating (GO:0048208) | 2.91038943 |
| 92 | sequestering of metal ion (GO:0051238) | 2.88623649 |
| 93 | axon cargo transport (GO:0008088) | 2.87866723 |
| 94 | neurotransmitter secretion (GO:0007269) | 2.87495656 |
| 95 | melanosome transport (GO:0032402) | 2.86994929 |
| 96 | establishment of synaptic vesicle localization (GO:0097480) | 2.86751066 |
| 97 | synaptic vesicle transport (GO:0048489) | 2.86751066 |
| 98 | adaptation of signaling pathway (GO:0023058) | 2.85614973 |
| 99 | protein localization to synapse (GO:0035418) | 2.85276675 |
| 100 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.83818743 |
| 101 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.81916049 |
| 102 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.81916049 |
| 103 | NADH dehydrogenase complex assembly (GO:0010257) | 2.81916049 |
| 104 | negative regulation of microtubule polymerization (GO:0031115) | 2.81846301 |
| 105 | regulation of exocytosis (GO:0017157) | 2.81357830 |
| 106 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.81106343 |
| 107 | nitric oxide mediated signal transduction (GO:0007263) | 2.80626579 |
| 108 | regulation of dopamine metabolic process (GO:0042053) | 2.80160861 |
| 109 | regulation of catecholamine metabolic process (GO:0042069) | 2.80160861 |
| 110 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.79750112 |
| 111 | vesicle transport along microtubule (GO:0047496) | 2.79522076 |
| 112 | membrane depolarization during action potential (GO:0086010) | 2.78296859 |
| 113 | protein localization to Golgi apparatus (GO:0034067) | 2.77717286 |
| 114 | dopamine biosynthetic process (GO:0042416) | 2.76575817 |
| 115 | positive regulation of vesicle fusion (GO:0031340) | 2.75718945 |
| 116 | peripheral nervous system neuron development (GO:0048935) | 2.75373651 |
| 117 | * regulation of hormone secretion (GO:0046883) | 2.75352172 |
| 118 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.75136953 |
| 119 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.75108800 |
| 120 | regulation of microtubule-based movement (GO:0060632) | 2.74182723 |
| 121 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.72044561 |
| 122 | organelle transport along microtubule (GO:0072384) | 2.72001309 |
| 123 | establishment of melanosome localization (GO:0032401) | 2.71767252 |
| 124 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.71076688 |
| 125 | pigment granule transport (GO:0051904) | 2.71036998 |
| 126 | vocalization behavior (GO:0071625) | 2.70716339 |
| 127 | inositol phosphate catabolic process (GO:0071545) | 2.69877431 |
| 128 | calcium ion-dependent exocytosis (GO:0017156) | 2.69874036 |
| 129 | response to corticosterone (GO:0051412) | 2.69748240 |
| 130 | protein polyglutamylation (GO:0018095) | 2.68926134 |
| 131 | exploration behavior (GO:0035640) | 2.68415493 |
| 132 | establishment of vesicle localization (GO:0051650) | 2.67563189 |
| 133 | transmission of nerve impulse (GO:0019226) | 2.67557300 |
| 134 | platelet dense granule organization (GO:0060155) | 2.65869847 |
| 135 | synaptic transmission, dopaminergic (GO:0001963) | 2.65705948 |
| 136 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65670308 |
| 137 | locomotory exploration behavior (GO:0035641) | 2.65155824 |
| 138 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.64093032 |
| 139 | * negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.62625047 |
| 140 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.62582762 |
| 141 | response to pain (GO:0048265) | 2.62343299 |
| 142 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.61859679 |
| 143 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.61698077 |
| 144 | synaptic transmission, glutamatergic (GO:0035249) | 2.61500673 |
| 145 | neuronal ion channel clustering (GO:0045161) | 2.61279114 |
| 146 | positive regulation of peptide hormone secretion (GO:0090277) | 2.60328663 |
| 147 | activation of adenylate cyclase activity (GO:0007190) | 2.60198336 |
| 148 | positive regulation of peptide secretion (GO:0002793) | 2.59734083 |
| 149 | phagosome maturation (GO:0090382) | 2.59378538 |
| 150 | regulation of glucocorticoid secretion (GO:2000849) | 2.58825104 |
| 151 | cerebellar granule cell differentiation (GO:0021707) | 2.57580630 |
| 152 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.57411134 |
| 153 | glandular epithelial cell differentiation (GO:0002067) | 2.57299837 |
| 154 | establishment of pigment granule localization (GO:0051905) | 2.57226850 |
| 155 | membrane repolarization (GO:0086009) | 2.56785680 |
| 156 | synapse assembly (GO:0007416) | 2.56769434 |
| 157 | behavioral response to ethanol (GO:0048149) | 2.56721627 |
| 158 | GDP-mannose metabolic process (GO:0019673) | 2.56690275 |
| 159 | positive regulation of action potential (GO:0045760) | 2.56104566 |
| 160 | * peptide hormone secretion (GO:0030072) | 2.56043485 |
| 161 | regulation of neurotransmitter secretion (GO:0046928) | 2.55851327 |
| 162 | melanosome localization (GO:0032400) | 2.54057860 |
| 163 | regulation of neurotransmitter uptake (GO:0051580) | 2.53668941 |
| 164 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.53450028 |
| 165 | regulation of synapse structural plasticity (GO:0051823) | 2.52881194 |
| 166 | auditory behavior (GO:0031223) | 2.51795426 |
| 167 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.51137336 |
| 168 | positive regulation of dendritic spine development (GO:0060999) | 2.50065520 |
| 169 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.48859262 |
| 170 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.48150124 |
| 171 | spinal cord association neuron differentiation (GO:0021527) | 2.47627754 |
| 172 | neuron-neuron synaptic transmission (GO:0007270) | 2.46866923 |
| 173 | dopamine transport (GO:0015872) | 2.45461947 |
| 174 | respiratory electron transport chain (GO:0022904) | 2.44523660 |
| 175 | adult walking behavior (GO:0007628) | 2.44454840 |
| 176 | regulation of gene silencing by RNA (GO:0060966) | 2.43495579 |
| 177 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.43495579 |
| 178 | regulation of gene silencing by miRNA (GO:0060964) | 2.43495579 |
| 179 | electron transport chain (GO:0022900) | 2.42922988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.03763444 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.44898357 |
| 3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.17903636 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.86086917 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.78811679 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.64342006 |
| 7 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.60626770 |
| 8 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.54730103 |
| 9 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52602425 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47598860 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.39557125 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.36717600 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34201766 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.34124681 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.31470341 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28774961 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25570404 |
| 18 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.21356635 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19072593 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.15194968 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.98961773 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.94381866 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.93960744 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.92934865 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.91966269 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90678673 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90678673 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.90314183 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89492183 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.88372539 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87958790 |
| 32 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.78607710 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.74654981 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.70285363 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68449010 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.67862993 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65481936 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65144273 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60574225 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60375808 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56761933 |
| 42 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.54470660 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.48280620 |
| 44 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.43384460 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39835541 |
| 46 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.38586183 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37924218 |
| 48 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.37811019 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37731733 |
| 50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37675226 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37472253 |
| 52 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.36610712 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36552776 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36171749 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.34763301 |
| 56 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.31972800 |
| 57 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.31964856 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29043105 |
| 59 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.26704728 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25807368 |
| 61 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24716433 |
| 62 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.22993156 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22358837 |
| 64 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.20651117 |
| 65 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.19276615 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19072491 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18174104 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17732964 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16701700 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14632162 |
| 71 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14596827 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13975991 |
| 73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13330510 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.12958240 |
| 75 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11510098 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11469637 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11024372 |
| 78 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.10724513 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09006234 |
| 80 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08485305 |
| 81 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07725536 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06697366 |
| 83 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06697366 |
| 84 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06583828 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05989727 |
| 86 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05379356 |
| 87 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05177926 |
| 88 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04927313 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04776779 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03952025 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 1.03801108 |
| 92 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.02817331 |
| 93 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.01902827 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01258274 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01174900 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00196787 |
| 97 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.99697396 |
| 98 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99479205 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98217041 |
| 100 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97939814 |
| 101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97110691 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96572298 |
| 103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95384899 |
| 104 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.95010843 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94815504 |
| 106 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94799523 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94602240 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93549186 |
| 109 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.91368161 |
| 110 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.91356281 |
| 111 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90678067 |
| 112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89952692 |
| 113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.88855382 |
| 114 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85706503 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85636019 |
| 116 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85400752 |
| 117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85212640 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84720301 |
| 119 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84532657 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84048426 |
| 121 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83287961 |
| 122 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82064467 |
| 123 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82009811 |
| 124 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82009811 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80556043 |
| 126 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.80018027 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79584060 |
| 128 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79556538 |
| 129 | AR_19668381_ChIP-Seq_PC3_Human | 0.77976845 |
| 130 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.76118139 |
| 131 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.74885234 |
| 132 | KDM2B_26808549_Chip-Seq_K562_Human | 0.73881260 |
| 133 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.73645852 |
| 134 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.73434058 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73007890 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73007890 |
| 137 | KDM2B_26808549_Chip-Seq_REH_Human | 0.72196049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004270_analgesia | 3.98741767 |
| 2 | MP0002735_abnormal_chemical_nociception | 3.94854092 |
| 3 | MP0010386_abnormal_urinary_bladder | 3.57641498 |
| 4 | MP0003183_abnormal_peptide_metabolism | 3.45758938 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.28222907 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.24792185 |
| 7 | MP0001986_abnormal_taste_sensitivity | 3.16474230 |
| 8 | MP0002909_abnormal_adrenal_gland | 3.12068415 |
| 9 | MP0006276_abnormal_autonomic_nervous | 3.09802290 |
| 10 | MP0003121_genomic_imprinting | 3.05443081 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 3.03406407 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.98606196 |
| 13 | MP0002733_abnormal_thermal_nociception | 2.93510803 |
| 14 | MP0003283_abnormal_digestive_organ | 2.90467754 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.85333780 |
| 16 | MP0003123_paternal_imprinting | 2.83195522 |
| 17 | MP0004858_abnormal_nervous_system | 2.77503880 |
| 18 | MP0005379_endocrine/exocrine_gland_phen | 2.73006762 |
| 19 | MP0002736_abnormal_nociception_after | 2.67493333 |
| 20 | MP0001970_abnormal_pain_threshold | 2.51661552 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.51252138 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.44050446 |
| 23 | MP0003880_abnormal_central_pattern | 2.37780685 |
| 24 | MP0000013_abnormal_adipose_tissue | 2.36616200 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 2.34162160 |
| 26 | MP0004043_abnormal_pH_regulation | 2.32866777 |
| 27 | * MP0002693_abnormal_pancreas_physiology | 2.30238115 |
| 28 | MP0002163_abnormal_gland_morphology | 2.26594046 |
| 29 | MP0006292_abnormal_olfactory_placode | 2.25644628 |
| 30 | MP0002638_abnormal_pupillary_reflex | 2.14017191 |
| 31 | MP0001944_abnormal_pancreas_morphology | 2.04963851 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.91260374 |
| 33 | MP0005499_abnormal_olfactory_system | 1.91260374 |
| 34 | MP0002272_abnormal_nervous_system | 1.90087290 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.90060708 |
| 36 | MP0002063_abnormal_learning/memory/cond | 1.84611492 |
| 37 | MP0002064_seizures | 1.74173794 |
| 38 | MP0009745_abnormal_behavioral_response | 1.72431669 |
| 39 | MP0002184_abnormal_innervation | 1.70802979 |
| 40 | MP0002572_abnormal_emotion/affect_behav | 1.69055125 |
| 41 | MP0008789_abnormal_olfactory_epithelium | 1.66051025 |
| 42 | MP0002102_abnormal_ear_morphology | 1.63972460 |
| 43 | MP0003122_maternal_imprinting | 1.61986630 |
| 44 | MP0004147_increased_porphyrin_level | 1.59583038 |
| 45 | MP0000678_abnormal_parathyroid_gland | 1.58762296 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.56393912 |
| 47 | MP0003329_amyloid_beta_deposits | 1.50610545 |
| 48 | MP0002653_abnormal_ependyma_morphology | 1.50359773 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.49761080 |
| 50 | MP0003195_calcinosis | 1.48990085 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.48129620 |
| 52 | MP0009046_muscle_twitch | 1.47657777 |
| 53 | MP0000955_abnormal_spinal_cord | 1.47358079 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.45662336 |
| 55 | MP0005535_abnormal_body_temperature | 1.40636830 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.39944561 |
| 57 | MP0002751_abnormal_autonomic_nervous | 1.36664105 |
| 58 | MP0001440_abnormal_grooming_behavior | 1.35431308 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.31636917 |
| 60 | MP0004133_heterotaxia | 1.31357153 |
| 61 | MP0003011_delayed_dark_adaptation | 1.31054314 |
| 62 | MP0003879_abnormal_hair_cell | 1.30492382 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 1.30413835 |
| 64 | * MP0002078_abnormal_glucose_homeostasis | 1.29938257 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.29029027 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.26104929 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.24414737 |
| 68 | MP0001188_hyperpigmentation | 1.10738441 |
| 69 | MP0002752_abnormal_somatic_nervous | 1.09589914 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 1.08901765 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.07643603 |
| 72 | MP0002557_abnormal_social/conspecific_i | 1.06173810 |
| 73 | MP0002152_abnormal_brain_morphology | 1.05888881 |
| 74 | MP0000538_abnormal_urinary_bladder | 1.04003090 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.03567780 |
| 76 | MP0001984_abnormal_olfaction | 1.02770270 |
| 77 | MP0002882_abnormal_neuron_morphology | 1.00890139 |
| 78 | MP0001765_abnormal_ion_homeostasis | 0.99796076 |
| 79 | MP0004924_abnormal_behavior | 0.97476054 |
| 80 | MP0005386_behavior/neurological_phenoty | 0.97476054 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 0.96103143 |
| 82 | MP0008569_lethality_at_weaning | 0.94689552 |
| 83 | MP0005423_abnormal_somatic_nervous | 0.93107766 |
| 84 | MP0004885_abnormal_endolymph | 0.92757138 |
| 85 | MP0003953_abnormal_hormone_level | 0.92673477 |
| 86 | MP0001270_distended_abdomen | 0.92335831 |
| 87 | MP0001905_abnormal_dopamine_level | 0.92254451 |
| 88 | MP0001348_abnormal_lacrimal_gland | 0.91965837 |
| 89 | MP0002229_neurodegeneration | 0.91759777 |
| 90 | MP0008872_abnormal_physiological_respon | 0.91192157 |
| 91 | MP0003861_abnormal_nervous_system | 0.91083452 |
| 92 | MP0001293_anophthalmia | 0.89288663 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.89152864 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.88461553 |
| 95 | MP0001486_abnormal_startle_reflex | 0.88229756 |
| 96 | MP0003633_abnormal_nervous_system | 0.86623360 |
| 97 | MP0003119_abnormal_digestive_system | 0.86308377 |
| 98 | MP0003634_abnormal_glial_cell | 0.84298918 |
| 99 | MP0002233_abnormal_nose_morphology | 0.83949643 |
| 100 | MP0002928_abnormal_bile_duct | 0.83778976 |
| 101 | MP0004142_abnormal_muscle_tone | 0.82108906 |
| 102 | MP0005310_abnormal_salivary_gland | 0.80851900 |
| 103 | MP0003136_yellow_coat_color | 0.79563314 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.78699194 |
| 105 | MP0000778_abnormal_nervous_system | 0.78648085 |
| 106 | MP0005187_abnormal_penis_morphology | 0.77591351 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.77151509 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.75879183 |
| 109 | MP0005464_abnormal_platelet_physiology | 0.75590970 |
| 110 | MP0002090_abnormal_vision | 0.75002242 |
| 111 | MP0005195_abnormal_posterior_eye | 0.74971739 |
| 112 | MP0000604_amyloidosis | 0.74629684 |
| 113 | MP0004742_abnormal_vestibular_system | 0.73550706 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.73385304 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.72631222 |
| 116 | MP0008260_abnormal_autophagy | 0.72253217 |
| 117 | MP0001299_abnormal_eye_distance/ | 0.72057475 |
| 118 | MP0000579_abnormal_nail_morphology | 0.72044451 |
| 119 | MP0003787_abnormal_imprinting | 0.69787505 |
| 120 | MP0002938_white_spotting | 0.69541358 |
| 121 | MP0001756_abnormal_urination | 0.68410191 |
| 122 | MP0003186_abnormal_redox_activity | 0.67945226 |
| 123 | MP0002822_catalepsy | 0.67485982 |
| 124 | MP0003718_maternal_effect | 0.67431105 |
| 125 | MP0001529_abnormal_vocalization | 0.67401709 |
| 126 | MP0000613_abnormal_salivary_gland | 0.67169658 |
| 127 | MP0005448_abnormal_energy_balance | 0.66485478 |
| 128 | MP0000462_abnormal_digestive_system | 0.65626652 |
| 129 | MP0005377_hearing/vestibular/ear_phenot | 0.65408996 |
| 130 | MP0003878_abnormal_ear_physiology | 0.65408996 |
| 131 | MP0005248_abnormal_Harderian_gland | 0.65206388 |
| 132 | MP0000631_abnormal_neuroendocrine_gland | 0.64956021 |
| 133 | MP0000003_abnormal_adipose_tissue | 0.64746408 |
| 134 | MP0000049_abnormal_middle_ear | 0.64096778 |
| 135 | MP0001664_abnormal_digestion | 0.63732112 |
| 136 | MP0003937_abnormal_limbs/digits/tail_de | 0.62388266 |
| 137 | MP0000639_abnormal_adrenal_gland | 0.61893366 |
| 138 | MP0003938_abnormal_ear_development | 0.61268849 |
| 139 | MP0000026_abnormal_inner_ear | 0.61060416 |
| 140 | * MP0000230_abnormal_systemic_arterial | 0.60699263 |
| 141 | MP0004145_abnormal_muscle_electrophysio | 0.59726657 |
| 142 | MP0003631_nervous_system_phenotype | 0.58847263 |
| 143 | MP0003959_abnormal_lean_body | 0.58304112 |
| 144 | MP0005636_abnormal_mineral_homeostasis | 0.58085627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.10253019 |
| 2 | Pheochromocytoma (HP:0002666) | 4.59910992 |
| 3 | Visual hallucinations (HP:0002367) | 4.47833454 |
| 4 | Myokymia (HP:0002411) | 4.47160138 |
| 5 | Polyphagia (HP:0002591) | 4.39845991 |
| 6 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.30025988 |
| 7 | Hypothermia (HP:0002045) | 4.23092716 |
| 8 | Neuroendocrine neoplasm (HP:0100634) | 4.22588639 |
| 9 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.95779196 |
| 10 | Septo-optic dysplasia (HP:0100842) | 3.88906172 |
| 11 | Hypoglycemic seizures (HP:0002173) | 3.73776503 |
| 12 | Abnormality of the labia minora (HP:0012880) | 3.72917562 |
| 13 | Symptomatic seizures (HP:0011145) | 3.71832436 |
| 14 | Dysautonomia (HP:0002459) | 3.64145147 |
| 15 | Thoracolumbar scoliosis (HP:0002944) | 3.62680750 |
| 16 | Abnormal hair whorl (HP:0010721) | 3.43333246 |
| 17 | Agitation (HP:0000713) | 3.41155255 |
| 18 | Focal motor seizures (HP:0011153) | 3.35553335 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.22160531 |
| 20 | Atonic seizures (HP:0010819) | 3.20323094 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.19694959 |
| 22 | Mucopolysacchariduria (HP:0008155) | 3.19694959 |
| 23 | Ulnar claw (HP:0001178) | 3.17550160 |
| 24 | Hypercortisolism (HP:0001578) | 3.14107150 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.10880919 |
| 26 | Hyperparathyroidism (HP:0000843) | 3.08223559 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.03372102 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.96747757 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.96747757 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.96747757 |
| 31 | Decreased circulating renin level (HP:0003351) | 2.96630316 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96019324 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96019324 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96019324 |
| 35 | Failure to thrive in infancy (HP:0001531) | 2.83433970 |
| 36 | Drooling (HP:0002307) | 2.83195569 |
| 37 | Menstrual irregularities (HP:0000858) | 2.80155841 |
| 38 | Hip dysplasia (HP:0001385) | 2.75582121 |
| 39 | Hepatoblastoma (HP:0002884) | 2.75068823 |
| 40 | Papilledema (HP:0001085) | 2.74999688 |
| 41 | Focal seizures (HP:0007359) | 2.73231669 |
| 42 | Action tremor (HP:0002345) | 2.72323692 |
| 43 | Optic nerve hypoplasia (HP:0000609) | 2.70486034 |
| 44 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.67265609 |
| 45 | Absence seizures (HP:0002121) | 2.63083783 |
| 46 | Postural tremor (HP:0002174) | 2.60276655 |
| 47 | Decreased muscle mass (HP:0003199) | 2.59285218 |
| 48 | Growth hormone deficiency (HP:0000824) | 2.57961037 |
| 49 | Lissencephaly (HP:0001339) | 2.56932421 |
| 50 | Generalized tonic-clonic seizures (HP:0002069) | 2.56372985 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.56047988 |
| 52 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.55887253 |
| 53 | Limb dystonia (HP:0002451) | 2.55838048 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54215757 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 2.54138873 |
| 56 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.53999588 |
| 57 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53548418 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53548418 |
| 59 | Excessive salivation (HP:0003781) | 2.53147080 |
| 60 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.51564295 |
| 61 | Abnormal eating behavior (HP:0100738) | 2.50656083 |
| 62 | Febrile seizures (HP:0002373) | 2.48405089 |
| 63 | Focal dystonia (HP:0004373) | 2.48143239 |
| 64 | Hypogonadotrophic hypogonadism (HP:0000044) | 2.47446494 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.46731290 |
| 66 | Congenital primary aphakia (HP:0007707) | 2.45820953 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 2.45177718 |
| 68 | Epileptic encephalopathy (HP:0200134) | 2.44442890 |
| 69 | Ketoacidosis (HP:0001993) | 2.43037801 |
| 70 | Abnormality of pain sensation (HP:0010832) | 2.42706619 |
| 71 | Impaired pain sensation (HP:0007328) | 2.42706619 |
| 72 | Late onset (HP:0003584) | 2.42061682 |
| 73 | Nephrogenic diabetes insipidus (HP:0009806) | 2.40951554 |
| 74 | Absent septum pellucidum (HP:0001331) | 2.38920945 |
| 75 | Dialeptic seizures (HP:0011146) | 2.37026511 |
| 76 | Abnormality of magnesium homeostasis (HP:0004921) | 2.34432356 |
| 77 | Abnormality of the corticospinal tract (HP:0002492) | 2.34143178 |
| 78 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.32293391 |
| 79 | Anxiety (HP:0000739) | 2.32097753 |
| 80 | Hyperglycinemia (HP:0002154) | 2.31728705 |
| 81 | Vaginal atresia (HP:0000148) | 2.31112283 |
| 82 | Genital tract atresia (HP:0001827) | 2.30142706 |
| 83 | Craniofacial dystonia (HP:0012179) | 2.27991895 |
| 84 | Torticollis (HP:0000473) | 2.27649399 |
| 85 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.26543936 |
| 86 | Spastic tetraplegia (HP:0002510) | 2.24943174 |
| 87 | Abnormal pancreas size (HP:0012094) | 2.24318346 |
| 88 | Menorrhagia (HP:0000132) | 2.22378351 |
| 89 | Amblyopia (HP:0000646) | 2.21671753 |
| 90 | Progressive cerebellar ataxia (HP:0002073) | 2.18314422 |
| 91 | Ankle clonus (HP:0011448) | 2.17927940 |
| 92 | Specific learning disability (HP:0001328) | 2.17040133 |
| 93 | Depression (HP:0000716) | 2.16470131 |
| 94 | Hyperthyroidism (HP:0000836) | 2.14167139 |
| 95 | Restlessness (HP:0000711) | 2.13445055 |
| 96 | Abnormality of midbrain morphology (HP:0002418) | 2.12975076 |
| 97 | Molar tooth sign on MRI (HP:0002419) | 2.12975076 |
| 98 | Renal Fanconi syndrome (HP:0001994) | 2.12303509 |
| 99 | Termporal pattern (HP:0011008) | 2.11641818 |
| 100 | Insidious onset (HP:0003587) | 2.11641818 |
| 101 | Intestinal atresia (HP:0011100) | 2.11246965 |
| 102 | Progressive macrocephaly (HP:0004481) | 2.09708806 |
| 103 | Truncal ataxia (HP:0002078) | 2.09368994 |
| 104 | Increased CSF lactate (HP:0002490) | 2.08000141 |
| 105 | Hyperglycemia (HP:0003074) | 2.05525109 |
| 106 | Pancreatic fibrosis (HP:0100732) | 2.05124300 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04550211 |
| 108 | Sleep apnea (HP:0010535) | 2.03897995 |
| 109 | Pachygyria (HP:0001302) | 2.00229668 |
| 110 | Hepatocellular necrosis (HP:0001404) | 1.99901932 |
| 111 | Adrenal overactivity (HP:0002717) | 1.99711179 |
| 112 | Cortical dysplasia (HP:0002539) | 1.99662790 |
| 113 | Progressive neurologic deterioration (HP:0002344) | 1.98373753 |
| 114 | Poor coordination (HP:0002370) | 1.97533073 |
| 115 | Hypokalemia (HP:0002900) | 1.97479599 |
| 116 | X-linked dominant inheritance (HP:0001423) | 1.96992100 |
| 117 | Broad-based gait (HP:0002136) | 1.96696059 |
| 118 | Oligomenorrhea (HP:0000876) | 1.96007004 |
| 119 | Increased mean platelet volume (HP:0011877) | 1.95234210 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94960462 |
| 121 | Cortical visual impairment (HP:0100704) | 1.94440708 |
| 122 | Mitochondrial inheritance (HP:0001427) | 1.92566725 |
| 123 | Generalized aminoaciduria (HP:0002909) | 1.92450176 |
| 124 | Testicular neoplasm (HP:0010788) | 1.91421388 |
| 125 | Hepatic necrosis (HP:0002605) | 1.91208834 |
| 126 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91147314 |
| 127 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.90879263 |
| 128 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.90879263 |
| 129 | Thyroid carcinoma (HP:0002890) | 1.90676595 |
| 130 | Labial hypoplasia (HP:0000066) | 1.89347181 |
| 131 | Cerebral edema (HP:0002181) | 1.88121053 |
| 132 | Type II lissencephaly (HP:0007260) | 1.85017582 |
| 133 | Spinal canal stenosis (HP:0003416) | 1.83278965 |
| 134 | Poor suck (HP:0002033) | 1.83220838 |
| 135 | Psychosis (HP:0000709) | 1.82852498 |
| 136 | Acute encephalopathy (HP:0006846) | 1.82704658 |
| 137 | Colon cancer (HP:0003003) | 1.82487133 |
| 138 | Thyroid-stimulating hormone excess (HP:0002925) | 1.82345824 |
| 139 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.81885902 |
| 140 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81817281 |
| 141 | Hypotension (HP:0002615) | 1.81607147 |
| 142 | Orthostatic hypotension (HP:0001278) | 1.80580912 |
| 143 | Anosmia (HP:0000458) | 1.80408133 |
| 144 | Bifid tongue (HP:0010297) | 1.79889726 |
| 145 | Urinary urgency (HP:0000012) | 1.79685882 |
| 146 | Delusions (HP:0000746) | 1.78414465 |
| 147 | Nasal speech (HP:0001611) | 1.78069537 |
| 148 | Abnormality of the septum pellucidum (HP:0007375) | 1.77623651 |
| 149 | Prolonged bleeding time (HP:0003010) | 1.77432440 |
| 150 | Osteomalacia (HP:0002749) | 1.77052686 |
| 151 | Long foot (HP:0001833) | 1.76783878 |
| 152 | Nephronophthisis (HP:0000090) | 1.76368460 |
| 153 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.75554905 |
| 154 | Broad alveolar ridges (HP:0000187) | 1.75544115 |
| 155 | Retinal dysplasia (HP:0007973) | 1.75425305 |
| 156 | Methylmalonic acidemia (HP:0002912) | 1.74504674 |
| 157 | Hypomagnesemia (HP:0002917) | 1.74193307 |
| 158 | Hypoplastic female external genitalia (HP:0012815) | 1.74034856 |
| 159 | Flared iliac wings (HP:0002869) | 1.73720299 |
| 160 | Narrow forehead (HP:0000341) | 1.73650386 |
| 161 | Protuberant abdomen (HP:0001538) | 1.73140542 |
| 162 | Gait imbalance (HP:0002141) | 1.73041739 |
| 163 | Scrotal hypoplasia (HP:0000046) | 1.72415453 |
| 164 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.71290428 |
| 165 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.71290428 |
| 166 | 3-Methylglutaconic aciduria (HP:0003535) | 1.70438270 |
| 167 | Upper limb muscle weakness (HP:0003484) | 1.70075723 |
| 168 | Supernumerary spleens (HP:0009799) | 1.70016314 |
| 169 | Growth hormone excess (HP:0000845) | 1.69953170 |
| 170 | Decreased testicular size (HP:0008734) | 1.69934169 |
| 171 | Episodic fever (HP:0001954) | 1.69846830 |
| 172 | Large for gestational age (HP:0001520) | 1.69571406 |
| 173 | Submucous cleft hard palate (HP:0000176) | 1.69039427 |
| 174 | Vacuolated lymphocytes (HP:0001922) | 1.68182820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 4.08006560 |
| 2 | NTRK3 | 4.06823272 |
| 3 | INSRR | 3.88515262 |
| 4 | PRKD3 | 3.14418460 |
| 5 | MAP3K2 | 3.01490976 |
| 6 | PASK | 2.98129851 |
| 7 | WNK3 | 2.77910834 |
| 8 | MINK1 | 2.71847100 |
| 9 | GRK5 | 2.66429816 |
| 10 | MAP3K9 | 2.50283642 |
| 11 | KSR2 | 2.45114696 |
| 12 | ARAF | 2.44419259 |
| 13 | RIPK4 | 2.40943152 |
| 14 | TNIK | 2.27389033 |
| 15 | MAP3K12 | 2.10887636 |
| 16 | STK16 | 1.91408542 |
| 17 | CAMKK2 | 1.90701619 |
| 18 | MAP2K7 | 1.87935818 |
| 19 | HIPK2 | 1.86748680 |
| 20 | MAP4K2 | 1.81636283 |
| 21 | MAPK15 | 1.75806096 |
| 22 | TRIM28 | 1.74757689 |
| 23 | MAP3K4 | 1.70702159 |
| 24 | MKNK2 | 1.68393703 |
| 25 | MARK1 | 1.67848647 |
| 26 | LIMK1 | 1.53633533 |
| 27 | EPHA3 | 1.53535770 |
| 28 | SIK3 | 1.48774782 |
| 29 | MAP3K1 | 1.46043077 |
| 30 | RET | 1.44577303 |
| 31 | CSNK1G1 | 1.41580842 |
| 32 | DYRK3 | 1.36583377 |
| 33 | PNCK | 1.34377100 |
| 34 | GRK1 | 1.32528305 |
| 35 | BRAF | 1.28733115 |
| 36 | DAPK2 | 1.25722348 |
| 37 | SCYL2 | 1.23734711 |
| 38 | CDK19 | 1.22075766 |
| 39 | MST4 | 1.22022490 |
| 40 | FLT3 | 1.21414594 |
| 41 | CASK | 1.21017469 |
| 42 | WNK4 | 1.17551998 |
| 43 | MAP2K4 | 1.16565827 |
| 44 | ZAK | 1.16529560 |
| 45 | MAPK13 | 1.16003927 |
| 46 | CAMKK1 | 1.13940927 |
| 47 | PLK3 | 1.13881466 |
| 48 | TAOK3 | 1.13167648 |
| 49 | PLK2 | 1.12864113 |
| 50 | UHMK1 | 1.12576097 |
| 51 | CSNK1A1L | 1.12278849 |
| 52 | PAK6 | 1.08199203 |
| 53 | BMPR2 | 1.07349501 |
| 54 | CDK5 | 1.07190055 |
| 55 | CDC42BPA | 1.07019739 |
| 56 | DAPK1 | 1.06199869 |
| 57 | TESK1 | 1.05194060 |
| 58 | TYRO3 | 1.01790052 |
| 59 | PRKCG | 1.00428864 |
| 60 | RPS6KA2 | 1.00233815 |
| 61 | PRKCE | 0.99652384 |
| 62 | AKT3 | 0.97626474 |
| 63 | BMX | 0.95871812 |
| 64 | ERN1 | 0.92556407 |
| 65 | EPHB2 | 0.92087050 |
| 66 | DYRK1A | 0.90422141 |
| 67 | LMTK2 | 0.85017441 |
| 68 | MKNK1 | 0.83636460 |
| 69 | PIM2 | 0.83077670 |
| 70 | MAP2K1 | 0.83071795 |
| 71 | PAK3 | 0.82730660 |
| 72 | CSNK1E | 0.82690024 |
| 73 | BCR | 0.82194507 |
| 74 | IRAK1 | 0.81747369 |
| 75 | PRKCH | 0.78342497 |
| 76 | FER | 0.77739842 |
| 77 | FRK | 0.77484177 |
| 78 | STK11 | 0.77298889 |
| 79 | PHKG1 | 0.75421803 |
| 80 | PHKG2 | 0.75421803 |
| 81 | CAMK2D | 0.74629331 |
| 82 | CAMK1G | 0.74245018 |
| 83 | NME1 | 0.73473390 |
| 84 | OXSR1 | 0.70925881 |
| 85 | CDK14 | 0.67335833 |
| 86 | KSR1 | 0.67316046 |
| 87 | BMPR1B | 0.64022833 |
| 88 | PKN1 | 0.63184991 |
| 89 | PTK2 | 0.62344892 |
| 90 | EPHA4 | 0.62080472 |
| 91 | MAPKAPK3 | 0.61968308 |
| 92 | LATS2 | 0.61935584 |
| 93 | CAMK1 | 0.61822096 |
| 94 | MATK | 0.59553877 |
| 95 | ALK | 0.59093548 |
| 96 | CAMK2A | 0.58701001 |
| 97 | ILK | 0.58462353 |
| 98 | SGK494 | 0.58368538 |
| 99 | SGK223 | 0.58368538 |
| 100 | CSNK1G2 | 0.58094521 |
| 101 | PLK1 | 0.57291708 |
| 102 | PAK1 | 0.56637154 |
| 103 | MAP2K2 | 0.56629495 |
| 104 | ADRBK1 | 0.55873417 |
| 105 | MYLK | 0.55084940 |
| 106 | PTK2B | 0.55055814 |
| 107 | CAMK2B | 0.54713987 |
| 108 | ADRBK2 | 0.51886271 |
| 109 | DYRK1B | 0.51648305 |
| 110 | DMPK | 0.49388134 |
| 111 | DAPK3 | 0.48750026 |
| 112 | SGK2 | 0.47720931 |
| 113 | CDK18 | 0.47558464 |
| 114 | PRKG1 | 0.47054488 |
| 115 | CDC7 | 0.46545590 |
| 116 | BCKDK | 0.44488033 |
| 117 | TAOK1 | 0.43832144 |
| 118 | PINK1 | 0.42777954 |
| 119 | SYK | 0.42648106 |
| 120 | FGR | 0.41837476 |
| 121 | PRKACA | 0.41126075 |
| 122 | PDPK1 | 0.39967449 |
| 123 | VRK1 | 0.39772627 |
| 124 | STK3 | 0.38697041 |
| 125 | PRKCA | 0.38677700 |
| 126 | PLK4 | 0.38379785 |
| 127 | SRPK1 | 0.37881843 |
| 128 | CDK15 | 0.37724167 |
| 129 | IRAK2 | 0.37592057 |
| 130 | ERBB2 | 0.37162644 |
| 131 | PRKCZ | 0.36995159 |
| 132 | NTRK2 | 0.36813802 |
| 133 | WNK1 | 0.35778716 |
| 134 | CSNK1G3 | 0.35772352 |
| 135 | MET | 0.35540725 |
| 136 | CAMK2G | 0.35445602 |
| 137 | PRKACG | 0.34864356 |
| 138 | PDGFRA | 0.34556922 |
| 139 | CSNK1A1 | 0.33744730 |
| 140 | PRKCI | 0.33326784 |
| 141 | BRSK1 | 0.33010746 |
| 142 | DYRK2 | 0.32678163 |
| 143 | FES | 0.30772414 |
| 144 | CDK11A | 0.29446413 |
| 145 | EIF2AK3 | 0.28396825 |
| 146 | MARK3 | 0.27535540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.47431863 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.50058566 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.36898131 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.95237939 |
| 5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.77651467 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.65176411 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.63250165 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.44861288 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.29884557 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.18049768 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 2.07320564 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.98623530 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.95805001 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.95615460 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.90440289 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.79921177 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76380944 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.73139251 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.71622518 |
| 20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.68844233 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.67996035 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.67543656 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63584469 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61312478 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59025023 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.57480014 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.50912182 |
| 28 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.49671437 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.48368073 |
| 30 | GABAergic synapse_Homo sapiens_hsa04727 | 1.44380727 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.42155330 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.38332257 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37635002 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.35392193 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.31984490 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31305418 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.30416598 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.28355308 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24831781 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.24121236 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.23321343 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22553822 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.21388163 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11285466 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08762518 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.07848044 |
| 47 | RNA polymerase_Homo sapiens_hsa03020 | 1.05126821 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03427852 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.03223175 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01882677 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01128511 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 0.99307214 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98123396 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 0.98086765 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94331851 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.93312108 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92751313 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91879007 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91093994 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90397870 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89476036 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88163002 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88013429 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87873150 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87433897 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87207385 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86519806 |
| 68 | Proteasome_Homo sapiens_hsa03050 | 0.86162760 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83960676 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82522713 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82164348 |
| 72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82104601 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81162541 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81024639 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79240822 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78922676 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77649069 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77498695 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77200485 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77192301 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76591843 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75067505 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.72574758 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.72123732 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71314505 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70658730 |
| 87 | Mismatch repair_Homo sapiens_hsa03430 | 0.68649044 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67744692 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67535985 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67325813 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67219145 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.66275864 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65942869 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65507849 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64974143 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64911434 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64807248 |
| 98 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64549947 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64288625 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63855194 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63295231 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.63047833 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.62333722 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61894536 |
| 105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61732698 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60569149 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59833273 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59153641 |
| 109 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58895005 |
| 110 | Ribosome_Homo sapiens_hsa03010 | 0.58411611 |
| 111 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58046021 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57710486 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56803880 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.56633508 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.56631499 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54996459 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53284590 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52807264 |
| 119 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52704539 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52092733 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49935939 |
| 122 | Purine metabolism_Homo sapiens_hsa00230 | 0.49904553 |
| 123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47820641 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46000721 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45794123 |
| 126 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44688142 |
| 127 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44085558 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43991377 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43070996 |
| 130 | RNA degradation_Homo sapiens_hsa03018 | 0.42161056 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.41935994 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41902187 |
| 133 | Tight junction_Homo sapiens_hsa04530 | 0.41581170 |
| 134 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40676572 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40616216 |
| 136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39523554 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38966944 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.37246591 |
| 139 | Tuberculosis_Homo sapiens_hsa05152 | 0.34519559 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32361828 |
| 141 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31165237 |
| 142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30388779 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30260433 |
| 144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30126289 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28942108 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28337277 |
| 147 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26880253 |
| 148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25580570 |
| 149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.24821624 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24011026 |

